Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element.

Miletti-González KE, Murphy K, Kumaran MN, Ravindranath AK, Wernyj RP, Kaur S, Miles GD, Lim E, Chan R, Chekmareva M, Heller DS, Foran D, Chen W, Reiss M, Bandera EV, Scotto K, Rodríguez-Rodríguez L.

J Biol Chem. 2012 Jun 1;287(23):18995-9007. doi: 10.1074/jbc.M111.318774. Epub 2012 Mar 20.

PMID:
22433859
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.

Ghosh S, Basu M, Roy SS.

J Biol Chem. 2012 Apr 27;287(18):15001-15. doi: 10.1074/jbc.M111.284034. Epub 2012 Jan 23.

PMID:
22270366
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway.

Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, Miki T, Wong AJ, Saya H.

J Cell Biol. 2001 Nov 26;155(5):755-62. Epub 2001 Nov 19.

PMID:
11714729
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells.

De Falco V, Tamburrino A, Ventre S, Castellone MD, Malek M, Manié SN, Santoro M.

Cancer Res. 2012 Mar 15;72(6):1449-58. doi: 10.1158/0008-5472.CAN-11-3320. Epub 2012 Jan 23.

PMID:
22271686
[PubMed - indexed for MEDLINE]
Free Article
5.

Mechanism and biological significance of CD44 cleavage.

Nagano O, Saya H.

Cancer Sci. 2004 Dec;95(12):930-5. Review.

PMID:
15596040
[PubMed - indexed for MEDLINE]
6.

MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.

Cheng W, Liu T, Wan X, Gao Y, Wang H.

FEBS J. 2012 Jun;279(11):2047-59. doi: 10.1111/j.1742-4658.2012.08589.x. Epub 2012 Apr 24.

PMID:
22498306
[PubMed - indexed for MEDLINE]
7.

TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.

Storci G, Sansone P, Mari S, D'Uva G, Tavolari S, Guarnieri T, Taffurelli M, Ceccarelli C, Santini D, Chieco P, Marcu KB, Bonafè M.

J Cell Physiol. 2010 Nov;225(3):682-91. doi: 10.1002/jcp.22264.

PMID:
20509143
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells.

Tamada M, Nagano O, Tateyama S, Ohmura M, Yae T, Ishimoto T, Sugihara E, Onishi N, Yamamoto T, Yanagawa H, Suematsu M, Saya H.

Cancer Res. 2012 Mar 15;72(6):1438-48. doi: 10.1158/0008-5472.CAN-11-3024. Epub 2012 Jan 31.

PMID:
22293754
[PubMed - indexed for MEDLINE]
Free Article
9.

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.

Desai B, Rogers MJ, Chellaiah MA.

Mol Cancer. 2007 Mar 7;6:18.

PMID:
17343740
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.

Kung CI, Chen CY, Yang CC, Lin CY, Chen TH, Wang HS.

Oncol Rep. 2012 Nov;28(5):1808-14. doi: 10.3892/or.2012.1993. Epub 2012 Aug 24.

PMID:
22922740
[PubMed - indexed for MEDLINE]
11.

Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.

Kagara N, Huynh KT, Kuo C, Okano H, Sim MS, Elashoff D, Chong K, Giuliano AE, Hoon DS.

Am J Pathol. 2012 Jul;181(1):257-67. doi: 10.1016/j.ajpath.2012.03.019. Epub 2012 May 21.

PMID:
22626806
[PubMed - indexed for MEDLINE]
Free Article
12.

CD44 and EpCAM: cancer-initiating cell markers.

Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M.

Curr Mol Med. 2008 Dec;8(8):784-804. Review.

PMID:
19075676
[PubMed - indexed for MEDLINE]
13.

Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.

Vesuna F, Lisok A, Kimble B, Raman V.

Neoplasia. 2009 Dec;11(12):1318-28.

PMID:
20019840
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Transcriptional upregulation of MT2-MMP in response to hypoxia is promoted by HIF-1α in cancer cells.

Zhu S, Zhou Y, Wang L, Zhang J, Wu H, Xiong J, Zhang J, Tian Y, Wang C, Wu H.

Mol Carcinog. 2011 Oct;50(10):770-80. doi: 10.1002/mc.20678. Epub 2011 Jul 12.

PMID:
21751260
[PubMed - indexed for MEDLINE]
15.

Acetylation and activation of STAT3 mediated by nuclear translocation of CD44.

Lee JL, Wang MJ, Chen JY.

J Cell Biol. 2009 Jun 15;185(6):949-57. doi: 10.1083/jcb.200812060. Epub 2009 Jun 8.

PMID:
19506034
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Vellon L, Menendez JA.

Cell Cycle. 2011 Nov 15;10(22):3871-85. doi: 10.4161/cc.10.22.17976. Epub 2011 Nov 15.

PMID:
22127234
[PubMed - indexed for MEDLINE]
Free Article
17.

TNFalpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells.

Barshishat M, Ariel A, Cahalon L, Chowers Y, Lider O, Schwartz B.

Clin Exp Metastasis. 2002;19(4):327-37.

PMID:
12090473
[PubMed - indexed for MEDLINE]
18.

Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.

Geng S, Guo Y, Wang Q, Li L, Wang J.

Arch Dermatol Res. 2013 Jan;305(1):35-47. doi: 10.1007/s00403-012-1260-2. Epub 2012 Jun 28.

PMID:
22740085
[PubMed - indexed for MEDLINE]
19.

Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.

Uchino M, Kojima H, Wada K, Imada M, Onoda F, Satofuka H, Utsugi T, Murakami Y.

BMC Cancer. 2010 Aug 10;10:414. doi: 10.1186/1471-2407-10-414.

PMID:
20696077
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.

Boldrup L, Coates PJ, Gu X, Nylander K.

J Pathol. 2007 Dec;213(4):384-91.

PMID:
17935121
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk